The American subsidiary would launch the product in manufacturing collaboration with Teyro Labs Pvt Ltd, an Indian pharmaceutical firm primarily based out of Chennai.
Learn extra: Natco Pharma to speculate Rs 2,500 crore in South Africa enlargement
In response to the assertion launched by the corporate, the launch is geared toward addressing the crucial scarcity of the drug within the US market.
Carboplatin injection is used for the remedy of superior ovarian carcinoma, together with first-line mixture remedy and palliative remedy of recurrent illness after prior chemotherapy, the discharge stated.
The injection recorded gross sales estimated at $27.8 million within the US for 12 months ending June 2026, the report stated, citing trade gross sales information.
